Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0005 USD
Change Today 0.00 / 0.00%
Volume 0.0
IMYN On Other Exchanges
As of 4:30 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

immunosyn corp (IMYN) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/19/14 - $0.0020
52 Week Low
12/31/14 - $0.0005
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IMMUNOSYN CORP (IMYN)

Related News

No related news articles were found.

immunosyn corp (IMYN) Related Businessweek News

No Related Businessweek News Found

immunosyn corp (IMYN) Details

Immunosyn Corporation, a development stage company, owns license to market, distribute, and sell a biopharmaceutical drug product, SF-1019 worldwide. SF-1019 is used for the treatment of various diseases and pathological conditions, primarily consisting of chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. Immunosyn Corporation also holds license for further improvements of SF-1019 and other compounds, which are developed under the same technology platform and that are chemically similar to SF-1019. The company was founded in 2006 and is headquartered in San Diego, California. Immunosyn Corporation operates as a subsidiary of Argyll Biotechnologies, LLC.

1 Employees
Last Reported Date: 11/19/10
Founded in 2006

immunosyn corp (IMYN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMYN:US $0.00 USD 0.00

IMYN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMYN.
View Industry Companies

Industry Analysis


Industry Average

Valuation IMYN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOSYN CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at